173 related articles for article (PubMed ID: 36282413)
1. Isoxazole carboxylic acid methyl ester-based urea and thiourea derivatives as promising antitubercular agents.
Sahoo SK; Ommi O; Maddipatla S; Singh P; Ahmad MN; Kaul G; Nanduri S; Dasgupta A; Chopra S; Yaddanapudi VM
Mol Divers; 2023 Oct; 27(5):2037-2052. PubMed ID: 36282413
[TBL] [Abstract][Full Text] [Related]
2. Exploration of Isoxazole-Carboxylic Acid Methyl Ester Based 2-Substituted Quinoline Derivatives as Promising Antitubercular Agents.
Kumar Sahoo S; Naiyaz Ahmad M; Kaul G; Nanduri S; Dasgupta A; Chopra S; Madhavi Yaddanapudi V
Chem Biodivers; 2022 Jul; 19(7):e202200324. PubMed ID: 35653161
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship of new chalcone linked 5-phenyl-3-isoxazolecarboxylic acid methyl esters potentially active against drug resistant Mycobacterium tuberculosis.
Sahoo SK; Rani B; Gaikwad NB; Ahmad MN; Kaul G; Shukla M; Nanduri S; Dasgupta A; Chopra S; Yaddanapudi VM
Eur J Med Chem; 2021 Oct; 222():113580. PubMed ID: 34116324
[TBL] [Abstract][Full Text] [Related]
4. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Pieroni M; Franzblau SG; Bishai WR; Kozikowski AP
Curr Top Med Chem; 2012; 12(7):729-34. PubMed ID: 22283815
[TBL] [Abstract][Full Text] [Related]
5. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
[TBL] [Abstract][Full Text] [Related]
8. Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.
Kumar Sahoo S; Maddipatla S; Nageswara Rao Gajula S; Naiyaz Ahmad M; Kaul G; Nanduri S; Sonti R; Dasgupta A; Chopra S; Madhavi Yaddanapudi V
Bioorg Med Chem; 2022 Jun; 64():116777. PubMed ID: 35487101
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs.
Mao J; Yuan H; Wang Y; Wan B; Pak D; He R; Franzblau SG
Bioorg Med Chem Lett; 2010 Feb; 20(3):1263-8. PubMed ID: 20022500
[TBL] [Abstract][Full Text] [Related]
10. Bioevaluation of quinoline-4-carbonyl derivatives of piperazinyl-benzothiazinones as promising antimycobacterial agents.
Sahoo SK; Gajula SNR; Ahmad MN; Kaul G; Nanduri S; Sonti R; Dasgupta A; Chopra S; Yaddanapudi VM
Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200168. PubMed ID: 35876343
[TBL] [Abstract][Full Text] [Related]
11. From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters.
Mao J; Yuan H; Wang Y; Wan B; Pieroni M; Huang Q; van Breemen RB; Kozikowski AP; Franzblau SG
J Med Chem; 2009 Nov; 52(22):6966-78. PubMed ID: 19863050
[TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial and anti-inflammatory activities of thiourea derivatives focusing on treatment approaches for severe pulmonary tuberculosis.
Calixto SD; Simão TLBV; Palmeira-Mello MV; Viana GM; Assumpção PWMC; Rezende MG; do Espirito Santo CC; de Oliveira Mussi V; Rodrigues CR; Lasunskaia E; de Souza AMT; Cabral LM; Muzitano MF
Bioorg Med Chem; 2022 Jan; 53():116506. PubMed ID: 34890996
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties.
North EJ; Scherman MS; Bruhn DF; Scarborough JS; Maddox MM; Jones V; Grzegorzewicz A; Yang L; Hess T; Morisseau C; Jackson M; McNeil MR; Lee RE
Bioorg Med Chem; 2013 May; 21(9):2587-99. PubMed ID: 23498915
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
[TBL] [Abstract][Full Text] [Related]
15. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
Dinakaran M; Senthilkumar P; Yogeeswari P; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):11-8. PubMed ID: 18078735
[TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, Pharmacological Evaluation, In silico Modeling, Prediction of Toxicity and Metabolism Studies of Novel 1-(substituted)-2-methyl- 3-(4-oxo-2-phenyl quinazolin-3(4H)-yl)isothioureas.
Sulthana MT; Alagarsamy V; Chitra K
Med Chem; 2021; 17(4):352-368. PubMed ID: 32807063
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents.
Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y
Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836
[TBL] [Abstract][Full Text] [Related]
19.
Quimque MTJ; Go AD; Lim JAK; Vidar WS; Macabeo APG
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511390
[TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis.
Segretti ND; Simões CK; Corrêa MF; Felli VMA; Miyata M; Cho SH; Franzblau SG; Fernandes JPDS
Tuberculosis (Edinb); 2016 Jul; 99():11-16. PubMed ID: 27449999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
